bucladesine has been researched along with latrunculin b in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, N; Ingerfeld, M; Jackson, SL; Moreno, S; Pereyra, E | 1 |
Bond, M; Duggirala, A; Kimura, TE; Newby, AC; Sala-Newby, GB; Smith, MC; White, S | 1 |
2 other study(ies) available for bucladesine and latrunculin b
Article | Year |
---|---|
Mucor rouxii ultrastructure: cyclic AMP and actin cytoskeleton.
Topics: Actins; Bridged Bicyclo Compounds, Heterocyclic; Bucladesine; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytoskeleton; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Mucor; Thiazolidines | 2006 |
The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.
Topics: Amides; Animals; Apoptosis Regulatory Proteins; Bridged Bicyclo Compounds, Heterocyclic; Bucladesine; Cell Proliferation; Colforsin; Connective Tissue Growth Factor; Cyclic AMP; Cysteine-Rich Protein 61; Epoprostenol; Gene Expression Regulation; Humans; Intracellular Signaling Peptides and Proteins; Male; Muscle, Smooth; Myocytes, Smooth Muscle; Primary Cell Culture; Proto-Oncogene Proteins c-myc; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction; Thiazolidines; Transcriptional Coactivator with PDZ-Binding Motif Proteins; Transforming Growth Factor beta2; YAP-Signaling Proteins | 2016 |